Homeopathic Medicines in Second Wave of COVID-19: Prognostic Factor Research.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Manchanda Raj Kumar, Miglani Anjali, Chakraborty Moumita, Kalsi Amrit, Meena Baljeet Singh, Kaur Prabhjeet, Saini Beenu, Arora Amit, Nagrath Cheshta, Kannoth Jithesh Thavarayil, Kudiyarasu Ram Kumar, Vardaan Rahul, Brahmachari Smita, Kumar Yogesh, Amitav B, Konthembath Pramod, Gupta Ankit, Lolugu Suresh Kumar, Goel Pawan, Arora Shelly, Balan Shirin, Sharma Kavita, Chawla Anu, Ray Malaya Kumar, Jacob Vineetha Susan, Kumar Udesh, Verma Vikas Kumar, Singh Rahul Kumar, Saha Abishes, Ghuliani Manjula, Kaur Paramjeet, Gora Shruti, Gupta Meeta, Sharma Brender, Rutten Lex
Аннотация
METHODS: This was a retrospective, multi-centred observational study performed from March 2021 to May 2021 on confirmed COVID-19 cases who were either in home isolation or at COVID Care Centres in Delhi, India. The data were collected from integrated COVID Care Centres where homeopathic medicines were prescribed along with conventional treatment. Only those cases that met a set of selection criteria were considered for analysis. The likelihood ratio (LR) was calculated for the frequently occurring symptoms of the prescribed medicines. An LR of 1.3 or greater was considered meaningful.
RESULTS: Out of 769 confirmed COVID-19 cases reported, 514 cases were selected for analysis, including 467 in home isolation. The most common complaints were cough, fever, myalgia, sore throat, loss of taste and/or smell, and anxiety. Most cases improved and there was no adverse reaction. Certain new symptoms, e.g., headache, dryness of mouth and conjunctivitis, were also seen. Thirty-nine medicines were prescribed, the most frequent being Bryonia alba followed by Arsenicum album, Pulsatilla nigricans, Belladonna, Gelsemium sempervirens, Hepar sulphuris, Phosphorus, Rhus toxicodendron and Mercurius solubilis. By calculating LR, the prescribing indications of these nine medicines were ascertained.
CONCLUSION: Add-on use of homeopathic medicines has shown encouraging results in the second wave of COVID-19 in integrated care facilities. Further COVID-related research is required to be undertaken on the most commonly prescribed medicines.